CECLOR Side Effects

6349120-5 | Blood Pressure Decreased, Bronchospasm, Erythema
on Sep 01, 2009 Female patient from GREECE , 52 years of age, weighting 165.3 lb, was diagnosed with respiratory tract infection, back pain (What is back pain?), dyslipidaemia, anxiety disorder and was treated with Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bronchospasm, erythema. Ceclor dosage: 750 Mg, 2/d. During the same period patient was treated with MESULID (1 D/f, Daily (1/d)) (View Mesulid Review and Mesulid Label ), INEGY (10 Mg, Daily (1/d)) (View Inegy Review and Inegy Label ), XANAX (0.5 D/f, Daily (1/d)) (View Xanax Review and Xanax Label ), NORGESIC /00070401/ (1 D/f, 2/d) (View Norgesic /00070401/ Review and Norgesic /00070401/ Label ). Patient was hospitalized.

6184274-5 | Haemolysis, Renal Impairment, Septic Shock
Patient was taking Ceclor (View Usage). Patient had the following side effects: haemolysis, renal impairment, septic shock on May 04, 2009 from CHINA Additional patient health information: Male patient , 60 years of age, was diagnosed with arthralgia and. Ceclor dosage: . During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ). Patient was hospitalized.

5917117-2 | Type Iv Hypersensitivity Reaction
Adverse event was reported on Oct 01, 2008 by a Male patient taking Ceclor (View Usage) (Dosage: 750 Mg, 2/d) was diagnosed with tonsillitis and. Location: GREECE , 52 years of age, After Ceclor was administered, patient had the following side effects: type iv hypersensitivity reaction. During the same period patient was treated with MESULID (100 Mg, 2/d) (View Mesulid Review and Mesulid Label ).

5840159-2 | Chest Discomfort, Tachycardia
on Jul 29, 2008 Female patient from CHINA , child 3 years of age, weighting 37.48 lb, was diagnosed with nasopharyngitis and was treated with Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, tachycardia. Ceclor dosage: 125 Mg, 3/d.


5823485-2 | Chest Discomfort, Tachycardia
on Jul 16, 2008 Female patient from CHINA , child 3 years of age, weighting 37.48 lb, was diagnosed with nasopharyngitis and was treated with Ceclor (View Usage). Patient had the following side effects: chest discomfort, tachycardia. Ceclor dosage: 125 Mg, 3/d.

5496470-0 | Hypersensitivity
Patient was taking Ceclor (View Usage). After Ceclor was administered, patient had the following side effects: hypersensitivity on Oct 11, 2007 from GREECE Additional patient health information: Female patient , 23 years of age, . Ceclor dosage: 750 Mg, 2/d.

5475956-9 | Anaphylactic Shock
Adverse event was reported on Sep 24, 2007 by a Female patient taking Ceclor (View Usage) (Dosage: 750 Mg, 2/d) . Location: GREECE , 23 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock.

5261101-1 | Hallucination, Nightmare
on Mar 05, 2007 Female patient from , child 6 years of age, was diagnosed with otitis media and was treated with Ceclor (View Usage). Patient had the following side effects: hallucination, nightmare. Ceclor dosage: 375 Mg, 3/d.

5158688-6 | Cardiac Failure
on Oct 26, 2006 Male patient from GREECE , 62 years of age, weighting 180.8 lb, was diagnosed with pyrexia and was treated with Ceclor (View Usage). After Ceclor was administered, patient had the following side effects: cardiac failure. Ceclor dosage: 1500 Mg, Daily (1/d). During the same period patient was treated with PONSTAN /CAN/ (View Ponstan /can/ Review and Ponstan /can/ Label ), DEPON (View Depon Review and Depon Label ).

5152524-X | Cardiac Failure, Pyrexia
Patient was taking Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, pyrexia on Oct 26, 2006 from GREECE Additional patient health information: Male patient , 62 years of age, weighting 180.8 lb, was diagnosed with pyrexia and. Ceclor dosage: 1500 Mg, Daily (1/d). During the same period patient was treated with PONSTAN /CAN/ (View Ponstan /can/ Review and Ponstan /can/ Label ), DEPON (View Depon Review and Depon Label ). Patient was hospitalized.

5145279-6 | Pyrexia
Adverse event was reported on Oct 26, 2006 by a Male patient taking Ceclor (View Usage) (Dosage: 750 Mg, 2/d) was diagnosed with prophylaxis and. Location: GREECE , 62 years of age, weighting 180.8 lb, Patient had the following side effects: pyrexia. During the same period patient was treated with PONSTAN /CAN/ (View Ponstan /can/ Review and Ponstan /can/ Label ), DEPON (View Depon Review and Depon Label ). Patient was hospitalized.

5121374-2 | Back Pain, Blood Lactate Dehydrogenase Increased, Chest Discomfort, Confusional State, Dialysis, Dizziness, Dyskinesia, Haematocrit Decreased
on Sep 11, 2006 Male patient from UNITED STATES , 63 years of age, was diagnosed with nail infection and was treated with Ceclor (View Usage). After Ceclor was administered, patient had the following side effects: back pain (What is back pain?), blood lactate dehydrogenase increased, chest discomfort, confusional state, dialysis (What is dialysis?), dizziness (What is dizziness?), dyskinesia, haematocrit decreased. Ceclor dosage: Oral. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), CARDURA (View Cardura Review and Cardura Label ), ZANTAC (View Zantac Review and Zantac Label ), VANQUISH (ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED, CAFFEI (View Vanquish (acetylsalicylic Acid, Aluminium Hydroxide Gel, Dried, Caffei Review and Vanquish (acetylsalicylic Acid, Aluminium Hydroxide Gel, Dried, Caffei Label ), SULINDAC (View Sulindac Review and Sulindac Label ). Patient was hospitalized.

5092268-6 | Alcohol Withdrawal Syndrome, Chest Discomfort, Dialysis, Dizziness, Haematocrit Decreased, Haemoglobin Decreased, Haemolytic Uraemic Syndrome, Hyperhidrosis, Nausea
on Aug 07, 2006 Male patient from UNITED STATES , 63 years of age, was diagnosed with nail infection and was treated with Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol withdrawal syndrome, chest discomfort, dialysis (What is dialysis?), dizziness (What is dizziness?), haematocrit decreased, haemoglobin decreased, haemolytic uraemic syndrome, hyperhidrosis, nausea (What is nausea?). Ceclor dosage: Oral. During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), CARDURA (View Cardura Review and Cardura Label ), ZANTAC (View Zantac Review and Zantac Label ), VANQUISH (ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED, CAFFEI (View Vanquish (acetylsalicylic Acid, Aluminium Hydroxide Gel, Dried, Caffei Review and Vanquish (acetylsalicylic Acid, Aluminium Hydroxide Gel, Dried, Caffei Label ), SULINDAC (View Sulindac Review and Sulindac Label ). Patient was hospitalized.

5092266-2 | Alcohol Withdrawal Syndrome, Chest Discomfort, Dialysis, Dizziness, Haematocrit Decreased, Haemoglobin Decreased, Haemolytic Uraemic Syndrome, Hyperhidrosis, Nausea
Patient was taking Ceclor (View Usage). Patient had the following side effects: alcohol withdrawal syndrome, chest discomfort, dialysis (What is dialysis?), dizziness (What is dizziness?), haematocrit decreased, haemoglobin decreased, haemolytic uraemic syndrome, hyperhidrosis, nausea (What is nausea?) on Aug 07, 2006 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with nail infection and. Ceclor dosage: Oral. During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), CARDURA (View Cardura Review and Cardura Label ), ZANTAC (View Zantac Review and Zantac Label ), VANQUISH (ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED, CAFFEI (View Vanquish (acetylsalicylic Acid, Aluminium Hydroxide Gel, Dried, Caffei Review and Vanquish (acetylsalicylic Acid, Aluminium Hydroxide Gel, Dried, Caffei Label ), SULINDAC (View Sulindac Review and Sulindac Label ). Patient was hospitalized.

5052097-6 | Hypersensitivity, Visual Acuity Reduced
Adverse event was reported on Jun 21, 2006 by a Female patient taking Ceclor (View Usage) (Dosage: 15 Ml, Daily (1/d), Only 2 Doses Given, Oral) was diagnosed with pharyngitis and. Location: GREECE , child 10 years of age, weighting 55.12 lb, After Ceclor was administered, patient had the following side effects: hypersensitivity, visual acuity reduced. Patient was hospitalized.

5040451-8 | Auricular Swelling, Oedema Peripheral, Pruritus, Swelling Face
on Jun 27, 2006 Female patient from UNITED STATES , 17 years of age, weighting 128.0 lb, was diagnosed with pharyngolaryngeal pain and was treated with Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: auricular swelling, oedema peripheral, pruritus, swelling face. Ceclor dosage: Unsure Po.

5034718-7 | Haematochezia
on Jun 02, 2006 Male patient from GREECE , weighting 18.74 lb, was diagnosed with otitis media acute and was treated with Ceclor (View Usage). Patient had the following side effects: haematochezia. Ceclor dosage: 40 Mg/kg, 3/d, Oral. Patient was hospitalized.

5025905-2 | Abdominal Tenderness, Asthenia, Bilirubin Conjugated Increased, Blood Bilirubin Increased, Fatigue, Feeling Abnormal, Hypersensitivity, Impaired Work Ability, Jaundice
Patient was taking Ceclor (View Usage). After Ceclor was administered, patient had the following side effects: abdominal tenderness, asthenia, bilirubin conjugated increased, blood bilirubin increased, fatigue, feeling abnormal, hypersensitivity, impaired work ability, jaundice (What is jaundice?) on Jun 12, 2006 from UNITED STATES Additional patient health information: Female patient , 39 years of age, . Ceclor dosage: 500 Mg Tid. During the same period patient was treated with CEPHALOSPORINS (View Cephalosporins Review and Cephalosporins Label ), CEFZIL (View Cefzil Review and Cefzil Label ), LEVORA 0.15/30 21 (View Levora 0.15/30-21 Review and Levora 0.15/30-21 Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALLEGRA (View Allegra Review and Allegra Label ), RHINOCORT (View Rhinocort Review and Rhinocort Label ).

4992819-3 | Arteriosclerosis, Back Pain, Blood Triglycerides Increased, Cataract, Chest Pain, Colonic Polyp, Coronary Artery Disease, Erectile Dysfunction, Hernia
Adverse event was reported on Oct 14, 2005 by a Male patient taking Ceclor (View Usage) (Dosage: ) was diagnosed with hypertension, spinal column stenosis, spinal osteoarthritis, gout (What is gout?), blood pressure (What is blood pressure?) and. Location: UNITED STATES , 58 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: arteriosclerosis, back pain (What is back pain?), blood triglycerides increased, cataract (What is cataract?), chest pain (What is chest pain?), colonic polyp (What is colonic polyp?), coronary artery disease (What is coronary artery disease?), erectile dysfunction (What is erectile dysfunction?), hernia (What is hernia?). During the same period patient was treated with CATAPRES (View Catapres Review and Catapres Label ), ADVIL (View Advil Review and Advil Label ), VIOXX (View Vioxx Review and Vioxx Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), DYTAC (View Dytac Review and Dytac Label ), FLEXERIL (View Flexeril Review and Flexeril Label ). Patient was hospitalized and became disabled.

4965747-7 | Rash
on Apr 05, 2006 Female patient from UNITED STATES , child 3 years of age, weighting 28.00 lb, was diagnosed with otitis media and was treated with Ceclor (View Usage). Patient had the following side effects: rash (What is rash?). Ceclor dosage: 250mg Tid Po.

4942665-1 | Acute Tonsillitis, C-reactive Protein Increased, Ecthyma, Gangrene, Lymph Node Pain, Scar, Streptococcal Infection
on Feb 22, 2006 Male patient from , child 4 years of age, was treated with Ceclor (View Usage). After Ceclor was administered, patient had the following side effects: acute tonsillitis, c-reactive protein increased, ecthyma, gangrene, lymph node pain, scar (What is scar?), streptococcal infection (What is streptococcal infection?). Ceclor dosage: Oral. During the same period patient was treated with SULTAMICILLIN (View Sultamicillin Review and Sultamicillin Label ). Patient was hospitalized.

4895937-3 | Atrial Fibrillation, Hypoaesthesia Oral
Patient was taking Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), hypoaesthesia oral on Dec 31, 2005 from CHINA Additional patient health information: Female patient , 26 years of age, . Ceclor dosage: Other, Oral.

4892078-6 | Arthralgia, Mobility Decreased, Oedema, Pain, Pyrexia, Urticaria
Adverse event was reported on Dec 22, 2005 by a Female patient taking Ceclor (View Usage) (Dosage: 825 Mg, Daily (1/d), Oral) was diagnosed with ear infection (What is ear infection?) and. Location: GREECE , 42 years of age, weighting 35.27 lb, Patient had the following side effects: arthralgia, mobility decreased, oedema, pain (What is pain?), pyrexia, urticaria.

4833218-4 | Face Oedema, Hypersensitivity, Urticaria
on Oct 31, 2005 Male patient from GREECE , 75 years of age, weighting 143.3 lb, was diagnosed with prophylaxis and was treated with Ceclor (View Usage). After Ceclor was administered, patient had the following side effects: face oedema, hypersensitivity, urticaria. Ceclor dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), TENORMIN (View Tenormin Review and Tenormin Label ), PLAVIX (View Plavix Review and Plavix Label ), VAXIGRIP (INFLUENZA VIRUS VACCINE POLYVALENT) (View Vaxigrip (influenza Virus Vaccine Polyvalent) Review and Vaxigrip (influenza Virus Vaccine Polyvalent) Label ).

4772911-9 | Angina Pectoris, Bronchospasm, Hyperhidrosis
on Aug 29, 2005 Male patient from BELGIUM , 46 years of age, weighting 187.4 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Ceclor (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, bronchospasm, hyperhidrosis. Ceclor dosage: 750 Mg/2 Day. During the same period patient was treated with BISOLVON (BROMPHEXINE HYDROCHLORIDE) (View Bisolvon (bromphexine Hydrochloride) Review and Bisolvon (bromphexine Hydrochloride) Label ). Patient was hospitalized.

4685998-9 | Stomach Discomfort, Vomiting
Patient was taking Ceclor (View Usage). Patient had the following side effects: stomach discomfort, vomiting on Jun 07, 2005 from Additional patient health information: Male patient , child 11 years of age, weighting 92.00 lb, . Ceclor dosage: .

4561520-2 | Disease Recurrence, Dizziness, Dyspnoea, Loss Of Consciousness, Mental Impairment, Mental Status Changes, Pneumonia, Respiratory Distress, Speech Disorder
Adverse event was reported on Jan 05, 2005 by a Female patient taking Ceclor (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: , 64 years of age, After Ceclor was administered, patient had the following side effects: disease recurrence, dizziness (What is dizziness?), dyspnoea, loss of consciousness, mental impairment, mental status changes, pneumonia (What is pneumonia?), respiratory distress, speech disorder. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.